Hyperglycemia and hyperinsulinemia upregulate cardiomyocyte SGLT1 by activating ERK, the transcription factors HNF-1 and Sp1, and the transcript stabilizer HuR. The gene discussed is ELAVL1; the disease is hyperinsulinism.